Back to blog

Relivaid Explained: The Science Behind Our Fast-Acting Pain Support

■ By Luke Lundstrom, Founder of Trelli
Last updated:
Relivaid Explained: The Science Behind Our Fast-Acting Pain Support

Pain is one of the most universal human experiences. Whether it is the dull throb of a tension headache, the sharp cramping of menstrual discomfort, or the aching soreness that follows a tough workout, most people reach for the same solution: conventional over-the-counter solutions. Relivaid was designed as a different kind of answer. It is a fast-acting, naturally derived pain support formula built on three clinically studied bioactives: a bio-optimized PEA complex, an amphiphilic ginger extract, and caffeine. Each selected for its human clinical evidence, dosed in alignment with studied amounts, and delivered in a form designed to actually reach the bloodstream.*

Why Two Pathways Are Better Than One

Pain is rarely the result of a single biological event. When the body experiences injury, physical exertion, or physiological stress, it initiates a cascade of overlapping inflammatory signals. Some travel through cyclooxygenase (COX) and lipoxygenase (LOX) enzyme pathways, which drive the production of prostaglandins and leukotrienes, molecules associated with swelling, heat, and pain sensitivity.1,2 Others travel through the nervous system and immune environment, where pain signals can be amplified or modulated depending on how well the body is regulating its own response.

Most conventional over-the-counter solutions work primarily on the COX pathway. That is effective for many types of pain, but it leaves meaningful parts of the ache cascade unaddressed. Relivaid is formulated to engage both the peripheral inflammation pathway via the ginger extract and the neuroimmune signaling pathway via the PEA complex, with caffeine acting as an enhancer that may amplify the effects of both and support faster onset.3

PEA Complex: Supporting the Body's Own Balancing System

Palmitoylethanolamide, or PEA, is a fatty acid amide the body produces naturally in response to pain, inflammation, and stress. It belongs to the same chemical family as endocannabinoids and has been studied since the 1950s, when researchers first isolated it from foods like egg yolks and peanuts and identified it as an inflammation-modulating molecule.4 Today it carries one of the more robust clinical evidence bases of any naturally derived compound for pain support.

PEA's primary studied mechanism involves activation of a nuclear receptor called PPAR-alpha. When PEA activates PPAR-alpha, it may help modulate the transcription of genes involved in the inflammatory response, supporting the body's ability to bring an overactive immune response back toward balance.4 Research also suggests PEA may help inhibit mast cell degranulation, the process by which immune cells release inflammatory compounds into surrounding tissue and may support balanced nerve signaling to help prevent pain receptors from becoming progressively more sensitive over time.4,5

The clinical evidence is meaningful. In a randomized controlled trial, PEA outperformed a nonsteroidal anti-inflammatory drug for TMJ, with fewer reported side effects.7 In a case series of seven patients with treatment-resistant neuropathic pain who had not responded adequately to conventional medications, PEA supplementation led to pain reductions ranging from 40 to 80 percent compared to baseline.8

Relivaid includes the PEA complex at 600 mg per dose, consistent with the dosage ranges used across the clinical literature, and uses an advanced delivery format to improve absorption relative to conventional PEA.

Amphiphilic Ginger Extract: Targeting Inflammation at the Source

Ginger (Zingiber officinale) has a long history of use in traditional medicine, and modern science has made meaningful progress in understanding the specific mechanisms behind its effects on pain and inflammation. What is less commonly understood is how much the form of a ginger determines whether those mechanisms are actually engaged in the body.

Ginger's bioactive compounds, gingerols and shogaols, have been studied for their potential to inhibit both COX-2, the enzyme involved in producing prostaglandin E2, and LOX-4, the enzyme involved in leukotriene production.1 That means ginger targets the same core inflammatory pathway as many conventional pain relievers, plus an additional one. Both gingerols and shogaols have also been studied for their antioxidant activity, with research suggesting they may help protect cells from oxidative stress.9

The clinical research on ginger spans several pain categories. A randomized controlled trial in 100 migraine patients found ginger comparable in effectiveness to sumatriptan, a commonly prescribed migraine medication, over two hours -- with significantly fewer adverse effects (4% versus 20%, p less than 0.05).10 A crossover randomized controlled trial in 168 women with primary dysmenorrhea found ginger comparable in pain reduction to a combination analgesic product at every measured time point, with no significant difference between groups and comparable tolerability.11 A meta-analysis drawing on data from four randomized controlled trials separately confirmed a significant effect of ginger in supporting relief from primary dysmenorrhea.12 And a randomized controlled trial in 74 healthy adults found that daily ginger supplementation resulted in approximately 25% less muscle soreness 24 hours after eccentric exercise compared to placebo.13

The ginger in Relivaid uses an advanced encapsulation system that significantly improves the water solubility and stability of gingerols compared to standard extracts, an important step, because gingerols are poorly absorbed and prone to rapid degradation in their unprotected form.14

Caffeine: The Enhancer

At 50 mg, roughly a cup of green tea, caffeine in Relivaid is not included for energy. It is included because caffeine is one of the most well-documented analgesic adjuvants in the clinical literature. It works primarily by blocking adenosine receptors, which reduces pain signal amplification, and by producing mild vasoconstriction that is particularly relevant for headache relief. Research also suggests caffeine may support the gastrointestinal absorption of other active compounds in the formula.3

A Cochrane systematic review of 19 randomized controlled trials in more than 7,200 participants found that adding caffeine to an analgesic increased the proportion of people achieving at least 50% pain relief by 5 to 10 percentage points, with no increase in adverse events.3 As an enhancer layered on top of two other active ingredients, that contribution is meaningful.

What to Expect

Relivaid is formulated for occasional pain support in healthy adults.* It is not a daily supplement and is not intended to replace medical care for chronic or underlying conditions. As with any ingestible, it is advisable to speak with a healthcare provider before use, particularly if you take prescription medications. 

The Bottom Line

Relivaid brings together three bioactives, each with a meaningful body of human clinical evidence, each dosed in alignment with studied amounts, and each delivered in a form designed to maximize absorption into a single, cohesive formula. It is a formulation built on the principle that natural and effective are not mutually exclusive; they just require the same scientific rigor we apply to anything else.*

 

References

  1. Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2007;14(2-3):123-128.

  2. Ojewole JA. Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother Res. 2006;20(9):764-772.

  3. Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;12:CD009281.

  4. LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D. The search for the palmitoylethanolamide receptor. Life Sci. 2005;77(14):1685-1698.

  5. Skaper SD, Facci L, Giusti P. Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets. 2014;13(10):1654-1666.

  6. Schweiger V, Schievano C, Martini A, et al. Systematic review and meta-analysis on the use of oral palmitoylethanolamide in chronic pain. Pain Ther. 2024.

  7. Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. J Orofac Pain. 2012;26(2):99-104.

  8. Hesselink JMK, Hekker TAM. Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series. J Pain Res. 2012;5:437-442.

  9. Semwal RB, Semwal DK, Combrinck S, Viljoen AM. Gingerols and shogaols: Important nutraceutical principles from ginger. Phytochemistry. 2015;117:554-568.

  10. Maghbooli M, Golipour F, Moghimi Esfandabadi A, Yousefi M. Comparison between the efficacy of ginger and sumatriptan in the ablative treatment of the common migraine. Phytother Res. 2014;28(3):412-415.

  11. Adib Rad H, Basirat Z, Bakouei F, et al. Effect of Ginger and Novafen on menstrual pain: A cross-over trial. Taiwan J Obstet Gynecol. 2018;57(6):806-809.

  12. Daily JW, Zhang X, Kim DS, Park S. Efficacy of ginger for alleviating the symptoms of primary dysmenorrhea: a systematic review and meta-analysis of randomized clinical trials. Pain Med. 2015;16(12):2243-2255.

  13. Black CD, Herring MP, Hurley DJ, O'Connor PJ. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. J Pain. 2010;11(9):894-903.

  14. Amalraj A, Varma K, Jude S, Raveendran Nair RV, Kuttappan S. Preparation and characterization of a novel bioavailable gingerol formulation using polar-nonpolar sandwich technology, its antioxidant potential, and an in vitro release study. ACS Food Sci Technol. 2021;1:1059-1067.

  15. Husain I, Idrisi M, Kotwal P, Khan IA, Khan SI. Ginger as a modulator of drug metabolizing enzymes and transporters: potential implications for herb-drug interactions. J Diet Suppl. Published online December 28, 2025.